United States · FDA National Drug Code directory

Risedronate Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-714_81702f21-3117-49ce-8e9b-2aa2648ba7c3
Product NDC
71205-714
Form
TABLET, FILM COATED
Composition / generic term
Risedronate Sodium
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20151130
Source listing expiry
20261231

Source-listed ingredients

  • RISEDRONATE SODIUM — 35 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (71205-714-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK · 71205-714-04

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →